Overview
FST-100 in the Treatment of Acute Adenoviral Conjunctivitis
Status:
Completed
Completed
Trial end date:
2014-05-23
2014-05-23
Target enrollment:
0
0
Participant gender:
All
All
Summary
This randomized, double masked, multi-center study is being conducted to support the safety and efficacy of FST-100 for the treatment of acute adenoviral conjunctivitis.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Shire
Criteria
Inclusion Criteria:- Have a clinical diagnosis of suspected acute adenoviral conjunctivitis in at least one
eye.
Exclusion Criteria:
- Have a known sensitivity to any of the components of FST-100 or FST-100 vehicle.